Phase 2 Vitiligo Trial, Recruiting

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who are willing to sign a consent form and follow the study's procedures
• People aged 18 to 65 years old, of any gender
• People who have been diagnosed with non-segmental vitiligo (a type of vitiligo that appears on both sides of the body in a scattered pattern)
• People whose vitiligo affects a certain minimum area of the face and body, as measured by standard scoring tools at both the screening and baseline appointments — whether the vitiligo is currently spreading or has been stable (confirm with trial site for specific score thresholds)
• Women who could become pregnant must have a negative pregnancy test at both the screening and baseline visits, and all eligible participants must use effective contraception from the time of consent until 30 days after the last dose of the study medication

Who may not be able to join:

• People who have segmental vitiligo, mixed vitiligo, or another skin pigmentation condition that could interfere with study assessments
• People where more than one-third of their facial or total vitiligo-affected areas also have white or depigmented hairs within the patches
• People who are currently pregnant or breastfeeding
• People with an active, latent, or inadequately treated tuberculosis infection
• People who have tested positive for HIV, have an active hepatitis B or C infection, or have untreated syphilis
• People with a current or past history of severe herpes infection
• People who have recently had a serious infection requiring hospital care or treatment with antiviral or antibiotic medicines taken by drip or by mouth
• People with a condition present from birth or developed over time that weakens the immune system, a history of certain opportunistic infections, or a condition that would require immune-suppressing medication during the study
• People with an uncontrolled thyroid condition, serious heart or blood vessel disease, or other unstable and serious ongoing health conditions
• People with severe mental health conditions, thoughts of suicide, or a history of alcohol or drug misuse within the past 6 months
• People who have had a cancer diagnosis within the past 5 years (certain fully treated skin cancers and early-stage cervical cell changes may be exceptions — confirm with trial site)
• People with a digestive condition that affects how the body absorbs medication, or who have had major surgery within 8 weeks before the first dose
• People with certain abnormal blood or organ function test results, including markers related to liver or kidney health, or low levels of certain blood cells (confirm specific values with trial site)
• People with a history of severe allergic reactions to medications or serious medication-related side effects
• People with any other condition that, in the treating doctor's judgement, could affect safe participation or ability to follow the study requirements

Important: Always verify eligibility with the trial site directly before applying.